However, according to the previous studies, when using the same brand of the qFIT and the same Hb threshold in an average-risk population, the sensitivities still had the wide ranges of variation for CRC (75–100%) (15, 16) and advanced adenoma (16–44%) (5, 18, 33, 34). The gene discussed is GSTM1; the disease is adenoma.